Search
  • Biocelect

Krintafel (tafenoquine) Approved for Radical Cure in USA

Updated: Jan 5

US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria


US FDA approves Krintafel (tafenoquine)
Download • 142KB

Biocelect Logo_Colour.png

Copyright 2019 Biocelect 

Australian Office: Suite 502, 139 Macquarie Street, Sydney NSW 2000, Australia

Registered Office Australia: Suite 405, Level 4, 51 Rawson Street, Epping NSW, 2121,  Australia 

Registered Office New Zealand: Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand

Biocelect acknowledges the Traditional Custodians of Australia and their continued connection to land,

sea and community. We pay our respects to the Elders, past and present. 

Privacy Policy

  • LinkedIn Social Icon